Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Loading...
Community
/
United States
/
Pharmaceuticals & Biotech
/
Agilent Technologies
Create a narrative
Agilent Technologies Community
NYSE:A Community
1
Narratives
written by author
0
Comments
on narratives written by author
36
Fair Values set
on narratives written by author
Community Investing Ideas
Agilent Technologies
Popular
Undervalued
Overvalued
Agilent Technologies
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
Global Healthcare Demand And PFAS Testing Will Drive Analytical Progress
Key Takeaways Sustained growth is driven by strong demand in healthcare, advanced materials, and regulatory-driven testing, with recurring revenue streams expanding Agilent's market and margin stability. Operational efficiencies, strategic pricing, and rapid adoption of innovative lab technologies position Agilent for ongoing margin improvement and above-market growth.
View narrative
US$138.83
FV
8.4% undervalued
intrinsic discount
5.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
24
users have followed this narrative
Updated
narrative